Home Coronavirus


Impact investing technology
Emerging managers' innovative investment strategies and hunger to outperform make them an attractive proposition for LPs looking to deploy capital in a dislocated market.
Our senior editorial teams covering PE, private debt, infrastructure, real estate and secondaries discuss the latest in how private markets are responding to the coronavirus pandemic. Plus: ways firms are helping people out in the crisis.
additional more
Experts from law firm Dechert outline ways GPs can raise additional capital for the portfolios.
covid-19 survey
See what investors think about allocations, first time funds, secondaries sales, GP performance and more in this downloadable presentation.
We caused a stir with reports of unnamed LP defaults this week; was it a storm in a teacup?
Helping hikers
The firm’s co-chief executives and board of directors have pledged 100% of their base salaries over the next six months to support portfolio companies.
Joncarlo Mark, a former senior portfolio manager at CalPERS, gives his take on the current market: how LP co-investments will fare, what the opportunity set looks like and whether LPs will have to ‘walk away’ from some capital commitments.
Co-investment opportunities have dried up along with the broader deal environment, but many LPs continue to seek ways to invest alongside GPs into deals.
Chemist in lab
Foreign PE firms looking to acquire healthcare-related companies in Europe can expect another three months of FDI review added to the deal process.
An exclusive investor survey conducted by PEI reveals three quarters of LPs will not reduce their target allocations to private markets in the face of the denominator effect.

Copyright PEI Media

Not for publication, email or dissemination